Ambry Genetics introduces BRCA1 and BRCA2 analysis

[News]

Ambry Genetics announced today the launch of BRCA1 and BRCA2 analysis as part of their comprehensive cancer-testing menu. Two genes will be offered as a stand alone test comprising of full gene sequencing and deletion/duplication analyses in addition to being incorporated as part of multiple hereditary cancer panels that test cancer susceptibility genes using next-generation sequencing technology.

More... (http://www.news-medical.net/news/20130614/Ambry-Genetics-introduces-BRCA1-and-BRCA2-analysis.aspx)